Cholic acid-based novel micellar nanoplatform for delivering FDA-approved taxanes.

about

Cholic acid-based novel micellar nanoplatform for delivering FDA-approved taxanes.

Item

http://www.wikidata.org/entity/Q45988720

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Cholic acid-based novel micellar nanoplatform for delivering FDA-approved taxanes.

@en

Cholic acid-based novel micellar nanoplatform for delivering FDA-approved taxanes.

@nl

type

Item

label

Cholic acid-based novel micellar nanoplatform for delivering FDA-approved taxanes.

@en

Cholic acid-based novel micellar nanoplatform for delivering FDA-approved taxanes.

@nl

prefLabel

Cholic acid-based novel micellar nanoplatform for delivering FDA-approved taxanes.

@en

Cholic acid-based novel micellar nanoplatform for delivering FDA-approved taxanes.

@nl

P1476

Cholic acid-based novel micellar nanoplatform for delivering FDA-approved taxanes.

@en

P2093

Ana Carolina Macarenco

http://www.w3.org/2001/XMLSchema#string

Anand Narayanan

http://www.w3.org/2001/XMLSchema#string

Darrion Yang

http://www.w3.org/2001/XMLSchema#string

Gaurav Bharadwaj

http://www.w3.org/2001/XMLSchema#string

Kit S Lam

http://www.w3.org/2001/XMLSchema#string

Letícia Salvador Vieira

http://www.w3.org/2001/XMLSchema#string

ShanChao Yang

http://www.w3.org/2001/XMLSchema#string

Viet Nhan

http://www.w3.org/2001/XMLSchema#string

Wenwu Xiao

http://www.w3.org/2001/XMLSchema#string

Xiaocen Li

http://www.w3.org/2001/XMLSchema#string

P2860

Nanomedicine therapeutic approaches to overcome cancer drug resistance

Self-assembling nanoparticles containing dexamethasone as a novel therapy in allergic airways inflammation

Albumin-bound paclitaxel: a next-generation taxane

THE DEVELOPMENT AND CLINICAL UTILITY OF THE TAXANE CLASS OF ANTIMICROTUBULE CHEMOTHERAPY AGENTS

Nanoparticle therapeutics: an emerging treatment modality for cancer

Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer.

A novel size-tunable nanocarrier system for targeted anticancer drug delivery.

Doubly amphiphilic poly(2-oxazoline)s as high-capacity delivery systems for hydrophobic drugs.

Well-defined, size-tunable, multifunctional micelles for efficient paclitaxel delivery for cancer treatment.

A smart and versatile theranostic nanomedicine platform based on nanoporphyrin.

P304

1153-1164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/NNM-2017-0361

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28447909

http://www.w3.org/2001/XMLSchema#string

P932

5480805

http://www.w3.org/2001/XMLSchema#string